Big-Time PBM Scrutiny: The Arkansas Case

Big-Time PBM Scrutiny The Arkansas Case

On Tuesday, January 13, the National Community Pharmacists Association (NCPA) has stated a case is turning its way through the courts.

“A few of PBMs (Pharmacy Benefit Management)  that opponent the most successful corporations in the world anyhow operate with the tiny mistake because of uncertainty over whether federal law acquires the states from setting them,” declared Mustafa Hersi, NCPA’s vice president and global counsel.

“They have left to control the cost of pharmaceutical prescriptions for patients, but they are making local stores out of business. There is a bipartisan agreement in the events that the PBMs must be ordered. Based on what is at stake, we are convinced that the Supreme Court will take the case.”

Slashed Reimbursement Rates

Hersi was true. Two days later, on Friday, January 10, the U.S. Supreme Court agreed to take on Rutledge v. the Pharmaceutical Care Management Association. PCMA is the licensed association that represents PBMs.

Arkansas Attorney General Leslie Rutledge began an investigation into PBM works in the state in 2018 when apothecaries began sounding the alarm about slashed reimbursement rates after the state’s largest insurer, Arkansas Blue Cross Blue Shield, changed its network within CVS Caremark’s PBM arrangement.

“We obtained many complaints from pharmacologists about how PBMs pay them for the cost of prescription medications,” Jessica Ray, a spokesperson for Rutledge’s office, told Pharmacy Today in July 2018.

In reply, Rutledge’s office began reviewing whether decreased payment rates and disparate reimbursement across several pharmacies were forbidden under provisions of Arkansas’s Deceptive Trade Practices Act. “Depending on what we find, we will aggressively go after the PBMs that infringed the law,” Ray replied.

Rutledge’s study concluded that PBMs outraged Act 900, which completely bans PBMs from paying drugstores below the medicines’ cost to acquire the medication. Act 900 also includes provisions that mandated the disclosure of PBMs’ hidden profit motives to customers and health plans.

Employee Benefits

The Eighth Circuit Court of Appeals sided with the PBM lobby in an ensuing prosecution, blocking Arkansas from enforcing Act 900.

The Circuit Court ruled that ERISA (Employee Retirement Income Security Act) preempts the state from restricting questionable business practices that are destroying local pharmacies. NCPA stated in its January 8 statement. The U.S. Solicitor General subsequently filed a brief with SCOTUS (Supreme Court Of The United States) that disagreed with the Eighth Circuit’s decision. SCOTUS declared its decision to hear the case on Friday, January 10.

Arkansas is hardly the only state fighting back against PBM practices and drastically decreased reimbursement rates. States across the country have passed or are acknowledging legislation allowing state regulation on how PBMs can operate.

Vera Videshina

Vera Videshina is considered to be one of the most promising and easy-to-read writers in the medical sphere. Her articles are published by lots of the American and European journals and sites annually. Medicine and everything connected with drugs has always been her hobby that Vera converted into the professional blog and personal achievement. Vera deals not only with medical topics, but also she writes about politics, general popular spheres, citizenship in multiple cities worldwide, etc. Her articles are always juicy and worth reading twice!

Be the first to comment on "Big-Time PBM Scrutiny: The Arkansas Case"

Leave a comment

Your email address will not be published.